S African decision to end nevirapine monotherapy condemned

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1448, 2004-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

S African decision to end nevirapine monotherapy condemned

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 458, 2004-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Increase of R-/S-Methadone Enantiomer Concentration Ratio in Serum of Patients Treated with Either Nevirapine or Efavirenz

By  

Drug Metabolism Letters, Vol. 2, Iss. 4, 2008-12 ,pp. : 269-274

Bentham Science Publishers

Access to resources Recommend Favorite

The decision to engage in end-of-life discussions: a structured approach for doctors in training

By Conn Rory   Berry Philip A  

Clinical Medicine, Vol. 10, Iss. 5, 2010-10 ,pp. : 468-471

Royal College Of Physicians

Access to resources Recommend Favorite

Multicenter phase II study of S-1 monotherapy as second-line chemotherapy for advanced biliary tract cancer refractory to gemcitabine

By Sasaki Takashi  

Investigational New Drugs, Vol. 30, Iss. 2, 2012-04 ,pp. : 708-713

Springer Publishing Company

Access to resources Recommend Favorite

Cabergoline, Pramipexole and Ropinirole Used as Monotherapy in Early Parkinson’s Disease: An Evidence-Based Comparison

By Inzelberg R.   Schechtman E.  

Drugs & Aging, Vol. 20, Iss. 11, 2003-01 ,pp. : 847-855

Adis International

Access to resources Recommend Favorite